Protocol for Digital Real-world Evidence trial for Adults with insomnia treated via Mobile (DREAM): an open-label trial of a prescription digital therapeutic for treating patients with chronic insomnia
Publication: Journal of Comparative Effectiveness Research
Abstract
Background: Cognitive behavioral therapy for insomnia (CBT-I) is underused in healthcare settings and is challenging for people with insomnia to access because of uneven geographical distribution of behavioral sleep medicine providers. Prescription digital therapeutics can overcome these barriers. This study evaluates the effectiveness of a specific digital CBT-I therapeutic. Materials & methods: Digital Real-world Evidence trial for Adults with insomnia treated via Mobile (DREAM) is a 9-week, open-label, decentralized clinical trial to collect real-world evidence for a digital therapeutic (Somryst™) delivering CBT-I to patients with chronic insomnia. The primary objective is to examine the effectiveness of Somryst to reduce self-reported insomnia symptoms and severity in a real-world population (n = 350). Conclusion: This pragmatic study seeks to assess the potential benefits of treating insomnia with an asynchronous, mobile, tailored prescription digital therapeutic.
Clinical trial registration: NCT04325464 (ClinicalTrials.gov)
Lay abstract
Chronic insomnia is linked to a range of health problems, including heart disease, chronic pain, high blood pressure and depression. A behavioral treatment called cognitive behavioral therapy for insomnia (CBT-I) is considered the first choice for helping patients overcome insomnia and reduce their risks of insomnia-related problems. Although the benefits of CBT-I have been established, it can be difficult for patients to access trained CBT-I therapists. One possible solution is to use digital forms of CBT-I, which patients can access on mobile devices. Somryst™ is a prescription digital therapeutic, which means it is authorized by the US FDA and has been proven effective in carefully-controlled clinical trials. Less is known, however, about how well the prescription digital therapeutic works in real-world settings. The Digital Real-world Evidence trial for Adults with insomnia treated via Mobile study (DREAM) will explore this question by evaluating a range of symptoms and outcomes in at least 350 patients with chronic insomnia who will use Somryst and be followed for 1 year.
Formats available
You can view the full content in the following formats:
References
Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med. Rev. 6(2), 97–111 (2003).
2.
Edinger JD, Arnedt JT, Bertisch SM et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J. Clin. Sleep Med. 17(2), 255–262 (2021).
•• Updated guidelines.
3.
Edinger JD, Arnedt JT, Bertisch SM et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J. Clin. Sleep Med. 17(2), 263–298 (2021).
•• Evidence base for updated guidelines.
4.
Daley M, Morin CM, LeBlanc M, Gregoire JP, Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 32(1), 55–64 (2009).
5.
Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep 30(2), 213–218 (2007).
6.
Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 30(3), 263–273 (2007).
• Health economics data.
7.
Morgenthaler T, Kramer M, Alessi C et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of sleep medicine report. Sleep 29(11), 1415–1419 (2006).
8.
Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of sleep medicine clinical practice guideline. J. Clin. Sleep Med. 13(2), 307–349 (2017).
9.
Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 165(2), 125–133 (2016).
•• Clinical practice guideline.
10.
Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J. Clin. Sleep Med. 4(5), 487–504 (2008).
11.
American Academy of Sleep Medicine. FDA requires new warning for several insomnia medications (2020). https://aasm.org/fda-new-warning-insomnia-medications/).
12.
Food & Drug Administration. FDA adds boxed warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines (2020). www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-risk-serious-injuries-caused-sleepwalking-certain-prescription-insomnia
13.
Wu JQ, Appleman ER, Salazar RD, Ong JC. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern. Med. 175(9), 1461–1472 (2015).
14.
Espie CA, Emsley R, Kyle SD et al. Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trial. JAMA Psychiatry 76(1), 21–30 (2019).
15.
Ancoli-Israel S, Lieberman JA 3rd. Insomnia in primary care: overcoming diagnostic and treatment barriers. Introduction. Postgrad. Med. 116(Suppl. 6), 4–6 (2004).
16.
Thomas A, Grandner M, Nowakowski S, Nesom G, Corbitt C, Perlis ML. Where are the behavioral sleep medicine providers and where are they needed? a geographic assessment. Behav. Sleep Med. 14(6), 687–698 (2016).
• Key data on geographic distribution of cognitive behavioral therapy for insomnia providers.
17.
MedCity News. Pear gets FDA clearance for insomnia therapeutic (2020). https://medcitynews.com/2020/03/pear-therapeutics-gets-fda-clearance-for-insomnia-therapeutic/
18.
Food & Drug Administration. Section 510(k) approval letter for Somryst, computerized behavioral therapy device for pschiatric disorders, Class II (2020). www.accessdata.fda.gov/cdrh_docs/pdf19/K191716.pdf
19.
Ritterband LM, Thorndike FP, Ingersoll KS et al. Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trial. JAMA Psychiatry 74(1), 68–75 (2016).
•• Pivotal trial.
20.
Christensen H, Batterham PJ, Gosling JA et al. Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial. Lancet Psychiatry 3(4), 333–341 (2016).
•• Pivotal trial.
21.
Zachariae R, Lyby MS, Ritterband LM, O'Toole MS. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia - a systematic review and meta-analysis of randomized controlled trials. Sleep Med. Rev. 30, 1–10 (2015).
22.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Edition). American Psychiatric Association, DC, USA (2013).
23.
Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34(5), 601–608 (2011).
24.
Kroenke K, Strine TW, Spitzer RL, Williams JBW, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J. Affect. Disord. 114(1), 163–173 (2009).
25.
Jordan P, Shedden-Mora MC, Lowe B. Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory. PLoS ONE 12(8), e0182162 (2017).
26.
Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15(4), 376–381 (1992).
27.
Gandek B, Ware JE, Aaronson NK et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J. Clin. Epidemiol. 51(11), 1171–1178 (1998).
28.
Dworkin SL. Sample size policy for qualitative studies using in-depth interviews. Arch. Sex. Behav. 41(6), 1319–1320 (2012).
29.
Muller M, Kogan S. Grounded theory method in human-computer interaction (HCI) and computer-supported cooperative work (CSCW) (2021). www.researchgate.net/profile/Michael_Muller/publication/265314097_Grounded_Theory_Method_in_HCI_and_CSCW/links/54dac1a70cf233119bc3e511/Grounded-Theory-Method-in-HCI-and-CSCW.pdf
30.
Dimond JP, Fiesler C, DiSalvo B, Pelc J. Qualitative data collection technologies: a comparison of instant messaging, email, and phone (2021). https://dl.acm.org/doi/abs/10.1145/2389176.2389218
31.
Furniss D, Blandford A, Curzon P. Confessions from a grounded theory PhD: experiences and lessons learnt. Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. 113–122 (2011).
Information & Authors
Information
Published In
Pages: 569 - 581
PubMed: 33682430
Copyright
© 2021 Pear Therapeutics Inc. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License
History
Received: 5 January 2021
Accepted: 10 February 2021
Published online: 8 March 2021
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Protocol for Digital Real-world Evidence trial for Adults with insomnia treated via Mobile (DREAM): an open-label trial of a prescription digital therapeutic for treating patients with chronic insomnia. (2021) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2021-0004
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Christopher B Miller, Danielle Bradley, Ian Wood, David Willens, Anupama Nair, Benjamin Brennan, Shane Bole, Laila Poisson, Shana Hall, Greig Thomson, Mika Hirata, David A Kalmbach, Christopher L Drake, Real-World Implementation and Impact of Digital CBT for Insomnia on Healthcare Utilization: A Propensity-Matched Controlled Study, Implementation Research and Practice, 10.1177/26334895251386306, 6, (2025).
- Cinja Koller, Marc Blanchard, Thomas Hügle, Assessment of digital therapeutics in decentralized clinical trials: A scoping review, PLOS Digital Health, 10.1371/journal.pdig.0000905, 4, 6, (e0000905), (2025).
- Zhu Chengyu, Huang Xueyan, Feng Ying, Research on disease management of chronic disease patients based on digital therapeutics: A scoping review, DIGITAL HEALTH, 10.1177/20552076241297064, 10, (2024).
- Frances P. Thorndike, Charles M. Morin, Joseph Ojile, Samantha Edington, Robert Gerwien, Jason C. Ong, Emerson M. Wickwire, Lee M. Ritterband, Heidi Riney, Effect of a prescription digital therapeutic for chronic insomnia on post-treatment insomnia severity, depression, and anxiety symptoms: results from the real-world DREAM study, Frontiers in Psychiatry, 10.3389/fpsyt.2024.1450615, 15, (2024).
- Yun Min Song, Jaegwon Jeong, Aurelio A. de los Reyes, Dongju Lim, Chul-Hyun Cho, Ji Won Yeom, Taek Lee, Jung-Been Lee, Heon-Jeong Lee, Jae Kyoung Kim, Causal dynamics of sleep, circadian rhythm, and mood symptoms in patients with major depression and bipolar disorder: insights from longitudinal wearable device data, eBioMedicine, 10.1016/j.ebiom.2024.105094, 103, (105094), (2024).
- Ojasav Sehrawat, Peter A. Noseworthy, Konstantinos C. Siontis, Tufia C. Haddad, John D. Halamka, Hongfang Liu, Data-Driven and Technology-Enabled Trial Innovations Toward Decentralization of Clinical Trials: Opportunities and Considerations, Mayo Clinic Proceedings, 10.1016/j.mayocp.2023.02.003, 98, 9, (1404-1421), (2023).
- Menglin Lu, Yaoyun Zhang, Junhang Zhang, Songfang Huang, Fei Huang, Tingna Wang, Fei Wu, Hongjing Mao, Zhengxing Huang, Comparative Effectiveness of Digital Cognitive Behavioral Therapy vs Medication Therapy Among Patients With Insomnia, JAMA Network Open, 10.1001/jamanetworkopen.2023.7597, 6, 4, (e237597), (2023).
- Rachel P Dreyer, Alyssa Berkowitz, Henry Klar Yaggi, Lynelle Schneeberg, Nilay D Shah, Lindsay Emanuel, Bhanuprakash Kolla, Molly Moore Jeffery, Mark Deeg, Keondae Ervin, Frances Thorndike, Joseph S Ross, Pre S cription Digita L Th E rap E utic for P atients with I nsomnia ( SLEEP-I ): a protocol for a pragmatic randomised controlled trial , BMJ Open, 10.1136/bmjopen-2022-062041, 12, 8, (e062041), (2022).
- Laura Dormer, Celebrating 10 years of the Journal of Comparative Effectiveness Research, Journal of Comparative Effectiveness Research, 10.2217/cer-2021-0249, 11, 1, (1-6), (2021).